Results 251 to 260 of about 322,983 (366)

Venous and arterial thrombosis in patients receiving immune checkpoint inhibitors. [PDF]

PLoS One
van Lent A, Puscasu R, Kaasjager KAH, Haitjema S, Suelmann BBM, Verhaar MC, Khairoun M, Ocak G.   +7 more
europepmc   +1 more source

Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin [PDF]

, 1969
Robert A. O’Reilly
openalex   +1 more source

Addendum to “Anticoagulant rodenticides in predatory birds 2007 & 2008: a Predatory Bird Monitoring Scheme (PBMS) report” [PDF]

, 2010
Llewellyn, N.R., Molenaar, F.M., Pereira, M.G., Potter, E.D., Sainsbury, A.W., Shore, R.F., Walker, L.A.   +6 more
core   +1 more source

Anticoagulants and Arteriosclerosis [PDF]

Postgraduate Medical Journal, 1955
openaire   +3 more sources

Impact of Age and Factor Xa Inhibitor Concentrations on Bleeding Risk in Patients with Atrial Fibrillation

Clinical Pharmacology &Therapeutics, EarlyView.
This study aimed to analyze differences in the exposure‐response relationship for factor Xa inhibitors (FXaI) between patients aged ≥ 80 and < 80 years. Patients with atrial fibrillation (AF) taking rivaroxaban, apixaban, or edoxaban were enrolled, and a single steady‐state trough concentration was measured.
Shin‐Yi Lin, Yen‐Bing Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Sung‐Chun Tang, Jiann‐Shing Jeng   +7 more
wiley   +1 more source

Cardiac Amyloidosis With Right Atrial Appendage Thrombus Detected After Left Atrial Appendage Occlusion. [PDF]

JACC Case Rep
Nakano K, Fukunaga M, Isotani A, Miyawaki N, Nakamura M, Morofuji T, Ishizu K, Hayashi M, Shirai S, Ando K.   +9 more
europepmc   +1 more source

Anticoagulants for Strokes [PDF]

BMJ, 1964
openaire   +2 more sources

ESR1 Variants and Subcontinental Genomic Ancestry: Insights from the 1000 Genomes Project and Native American Populations

Clinical Pharmacology &Therapeutics, EarlyView.
The ESR1 gene is relevant in breast cancer treatments in the pharmacogenetics context. However, Native, African, and mixed populations are known to be underrepresented in genomic studies. This is particularly important given that the difference in variants' frequencies among different populations can lead to population‐specific clinical implications ...
Mariana M. Scudeler, Caíque Manóchio, Bruno Miwa, Guilherme Belfort‐Almeida, Lucas Faria‐Costa, Cesar Sanchez, Carlos Padilla, Omar Caceres, Eduardo Tarazona‐Santos, Heinner Guio, Timothy D. O'Connor, Fernanda Rodrigues‐Soares   +11 more
wiley   +1 more source

Clinical outcomes and hemorrhagic or thromboembolic risks in decompressive craniectomy for patients taking antiplatelet or anticoagulant therapy. [PDF]

Neurosurg Rev
Scerrati A, Scanferla G, Sgarbanti L, Mantovani G, Angelini C, Flacco ME, Maugeri R, Bonosi L, Iacopino DG, Tumbiolo S, Adorno A, Brunasso L, Lofrese G, Rosetti V, Tosatto L, Somma T, Cavallo LM, Lombardi S, Sturiale CL, Signorelli F, Auricchio AM, Menna G, Ricciardi L, Montemurro N, Raneri F, Rustemi O, Zambon G, Cavallo MA, De Bonis P.   +28 more
europepmc   +1 more source

The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide* [PDF]

, 1965
Robert T. Breckenridge, Oscar D. Ratnoff
openalex   +1 more source